Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SKL | Ann: SPH Notice - FirstCape Group Limited | 23/09/24 | 0 | 47 | |||
|
|||||||
SKL | Ann: D&O Ongoing Disclosure - David Cushing | 04/09/24 | 0 | 63 | |||
|
|||||||
SKL | Ann: Notice of Meeting | 02/09/24 | 0 | 60 | |||
|
|||||||
SKL | Ann: Director Nominations | 16/08/24 | 0 | 66 | |||
|
|||||||
SKL | Ann: Skellerup delivers robust result in challenging markets | 15/08/24 | 0 | 145 | |||
|
|||||||
SKL | Ann: FY24 Results Announcement Date & Presentation | 02/08/24 | 0 | 128 | |||
|
|||||||
SKL | Ann: SPH Notice - Forsyth Barr Investment Management Limited | 10/06/24 | 0 | 115 | |||
|
|||||||
SKL | Ann: Ongoing Disclosure Notice - Strowger | 10/06/24 | 0 | 108 | |||
|
See All Discussions